Investor suits against AbbVie pile up in wake of Humira kickback allegations

Allegations that AbbVie hired nurse "ambassadors" to boost Humira prescriptions have taken a toll on the company's stock price—and investors aren't happy. Now, they have more than one chance to try to collect on their losses, thanks to a new putative class action, the second in less than a month.